Liminal BioSciences Inc operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Liminal BioSciences Inc with three other
companies in this sector in CANADA :
Mirati Therapeutics Inc
(2019
sales of 4.41 million Canadian Dollars [US$3.30 million]
of which 100%
was Contract & License),
Pond Technologies Holdings Inc
(6.14 million Canadian Dollars [US$4.58 million]
of which 58%
was Nutraceutical Products), and
VBI Vaccines Inc
(2.94 million Canadian Dollars [US$2.19 million]
of which 76%
was R&D Service revenue).
Sales Analysis.
Sales fell dramatically in 2019:
Liminal BioSciences Inc reported sales of C$4.90 million (US$3.66 million)
for the
year ending
December of 2019.
This
represents
a
sharp
decrease of 89.6%
versus 2018, when the company's sales were C$47.37 million.